We serve (2-methyl-2-phenylpropyl) acetate CAS:18755-52-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: (2-methyl-2-phenylpropyl) acetate
CAS.NO:18755-52-7
Synonyms:
Benzeneethanol,b,b-dimethyl-,1-acetate
2-methyl-2-phenylpropyl acetate
(2-acetoxy-1,1-dimethylethyl)benzene
2-Phenylisobutyl acetate
acetic acid-(2-methyl-2-phenyl-propyl ester)
Neophyl acetate
Molecular Formula: C12H16O2
Molecular Weight:192.25400
Physical and Chemical Properties:
Density: 0.998g / cm3
Boiling point: 256.8ºC at 760mmHg
Melting point: /
Flash point: 100.8ºC
Refractive index: 1.489
Specification:
Appearance: white crystalline powder
Purity:≥99%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Fexofenadine hydrochloride CAS:138452-21-8
Intermediates of Fexofenadine CAS:83799-24-0
Contact us for information like (2-methyl-2-phenylpropyl) acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Neophyl acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-2-phenylpropyl acetate Use and application,2-Phenylisobutyl acetate technical grade,usp/ep/jp grade.
Related News: Health officials said it remained unclear where he had developed the disease.1,2,3,4,5-Pentafluorobenzene manufacturer Health officials said it remained unclear where he had developed the disease.1,4,7,10-tetraazacyclododecane supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.2-imidazo[1,2-a]pyridin-3-ylacetic acid vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.
